Top Stocks to Buy/Sell Today - 24 April, 2024

The market opened with a positive sentiment and maintained a steady trajectory within a constrained range of 22350-22430 for the entire session. The closing marked a modest gain of 0.14 percent.

The Nifty Midcap 100 index outperformed the Nifty 50, concluding the session on an upswing with a gain of 1.06 percent. Within the sector landscape, Realty and FMCG emerged as frontrunners, demonstrating strength and resilience. In contrast, Pharma and Healthcare encountered challenges, resulting in a weaker performance.

The options market data reveals a concentration of open interest at the 22500 call level, while on the put side, interest is focused at 22000. An analysis of the current option chain suggests a prevalence of call writing activity over put writing, hinting at a bearish sentiment in the market.

The Volume Weighted Average Price (VWAP) provides an indication of a trading range between 22240 and 22490 for the upcoming session. The Max Pain is projected at 22300 spot, with a CE/PE Combined Residual Premium/Pain Value of 1158.9 Crores.

In the cash market, Foreign Institutional Investors (FIIs) engaged in net selling with a total activity amounting to 3044.54 crore. Domestic Institutional Investors (DIIs), on the other hand, also exhibited net selling of 2918.94 crore.

Top Stocks to Buy Today:

1) TATACONSUM

Buy TATACONSUM shares in intraday timeframe at CMP Rs. 1121.05

2) MCX

Buy MCX shares in intraday timeframe at CMP Rs. 3820.8

3) EXIDEIND

Buy EXIDEIND shares in intraday timeframe at CMP Rs. 444.7

4) M&M

Buy M&M shares in intraday timeframe at CMP Rs. 2064.9

Top Stocks to Short Today:

1) DELHIVERY

Sell DELHIVERY shares in intraday timeframe at CMP Rs. 454.6

2) GSPL

Sell GSPL shares in intraday timeframe at CMP Rs. 302.7

3) BALAMINES

Sell BALAMINES shares in intraday timeframe at CMP Rs. 2261.9

4) CYIENT

Sell CYIENT shares in intraday timeframe at CMP Rs. 1929.45

Disclaimer: Remember, the market is a living beast, and even the most informed predictions can be devoured by unforeseen events. While this analysis is based on a thorough rule-based research, the ultimate decision to buy or sell rests with you. Do your own due diligence, consider your risk tolerance, and craft a strategy that aligns with your financial goals. Stratzy provides insights, not guarantees, and cannot be held responsible for any gains or losses incurred in your trading activities. Invest wisely, trade responsibly, and may the market gods favor you!